Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-cell Lymphoma

Explore clinical trials studying Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

213 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-cell Lymphoma trial results

Completed

Carfilzomib Plus Belinostat in Relapsed/Refractory NHL

NCT02142530

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy

NCT01626352

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Florida Cancer Specialists-South Fort Myers, Florida, United States
  • Woodlands Medical Specialists Pensacola, Florida, United States
  • Florida Cancer Specialists North St. Petersburg, Florida, United States
  • Space Coast Cancer Center Titusville, Florida, United States
View Trial Details
Completed

An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

NCT01340443

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • The Affiliated Hospital of Military Medical Sciences(The 307th Hospital of Chinese PLA) Beijing, China
  • the First Hospital of Jilin University Changchun, China
  • Xiangya Hospital of Centre-South University Changsha, China
  • Changzhou First People's Hospital Changzhou, China
View all 24 locations
View Trial Details
Completed

Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL

NCT01562977

Conditions
Aggressive Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Duran i Reynals Sabadell, Barcelona, Spain
  • Hospital SAS de Jerez Jerez de la Frontera, Cádiz, Spain
  • Hospital Dr. Jose Molina Orosa Arrecife, Lanzarote, Spain
View all 28 locations
View Trial Details
Completed

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

NCT00355199

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Clinica di Ematologia - Nuovo Ospedale Torrette Ancona, Italy
  • U.O. Ematologia - Ospedali Riuniti di Bergamo Bergamo, Italy
  • Divisione di Ematologia - Ospedale Centrale di Bolzano Bolzano, Italy
  • CTMO - Ematologia - Ospedale "R. Binaghi" Cagliari, Italy
View all 16 locations
View Trial Details
Completed

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

NCT00790036

Conditions
Diffuse Large B-cell Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations
  • Ironwood Cancer and Research Centers SC Chandler, Arizona, United States
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (3) La Jolla, California, United States
  • USC/Kenneth Norris Comprehensive Cancer Center Dept.ofNorrisMedicalCenter(4) Los Angeles, California, United States
View all 202 locations
View Trial Details
Completed

Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma

NCT01234467

Conditions
Diffuse Large B-cell Lymphoma, Diffuse Large-Cell Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Northeast Medical Center Concord, North Carolina, United States
  • Moses Cone Regional Cancer Center Greensboro, North Carolina, United States
View Trial Details
Completed

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00075478

Conditions
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
Locations
  • OHSU Cancer Institute-Southern Region Medford, Oregon, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details

Related conditions